Michael E. Thase, MD

Original Research

Case-Control Analyses of the Impact of Pharmacotherapy on Prospectively Observed Suicide Attempts and Completed Suicides in Bipolar Disorder: Findings From STEP-BD

June 30, 2008

Lauren B. Marangell, Ellen B. Dennehy, Stephen R. Wisniewski, et al

Original Research

Efficacy of Quetiapine Monotherapy for the Treatment of Depressive Episodes in Bipolar I Disorder: A Post Hoc Analysis of Combined Results From 2 Double-Blind, Randomized, Placebo-Controlled Studies

May 11, 2008

Richard H. Weisler, Joseph R. Calabrese, Michael E. Thase, et al

Original Research

Transcranial Magnetic Stimulation in the Acute Treatment of Major Depressive Disorder: Clinical Response in an Open-Label Extension Trial

March 14, 2008

David H. Avery, Keith E. Isenberg, Shirlene M. Sampson, et al

Educational Activity

Management of Patients With Treatment-Resistant Depression

March 14, 2008

Michael E. Thase

Original Research

Comparing the Rapidity of Response During Treatment of Major Depressive Disorder With Bupropion and the SSRIs: A Pooled Survival Analysis of 7 Double-Blind, Randomized Clinical Trials

December 14, 2007

George I. Papakostas, Stuart A. Montgomery, Michael E. Thase, et al

Original Research

Self-Reported History of Manic/Hypomanic Switch Associated With Antidepressant Use: Data From the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

October 15, 2007

Christine J. Truman, Joseph F. Goldberg, S. Nassir Ghaemi, et al

Original Research

The Prevention of Recurrent Episodes of Depression With Venlafaxine for Two Years (PREVENT) Study: Outcomes From the 2-Year and Combined Maintenance Phases

August 15, 2007

Martin B. Keller, Madhukar H. Trivedi, Michael E. Thase, et al

Original Research

Prevention of Recurrent Episodes of Depression With Venlafaxine ER in a 1-Year Maintenance Phase From the PREVENT Study

July 16, 2007

James H. Kocsis, Michael E. Thase, Madhukar H. Trivedi, et al

Article

Recognition and Diagnosis of Atypical Depression

July 16, 2007

Michael E. Thase

Educational Activity

Translating the Evidence on Atypical Depression Into Clinical Practice

April 15, 2007

Mark Hyman Rapaport, Michael E. Thase

Educational Activity

Treating DSM-IV Depression with Atypical Features

April 15, 2007

Jonathan W. Stewart, Michael E. Thase

Educational Activity

Preventing Recurrent Depression: Long-Term Treatment for Major Depressive Disorder

March 15, 2007

Pierre Blier, Martin B. Keller, Mark H. Pollack, et al

Case-Control Analyses of the Impact of Pharmacotherapy on Prospectively Observed Suicide Attempts and Completed Suicides in Bipolar Disorder: Findings From STEP-BD

Efficacy of Quetiapine Monotherapy for the Treatment of Depressive Episodes in Bipolar I Disorder: A Post Hoc Analysis of Combined Results From 2 Double-Blind, Randomized, Placebo-Controlled Studies

Transcranial Magnetic Stimulation in the Acute Treatment of Major Depressive Disorder: Clinical Response in an Open-Label Extension Trial

Management of Patients With Treatment-Resistant Depression

Comparing the Rapidity of Response During Treatment of Major Depressive Disorder With Bupropion and the SSRIs: A Pooled Survival Analysis of 7 Double-Blind, Randomized Clinical Trials

Self-Reported History of Manic/Hypomanic Switch Associated With Antidepressant Use: Data From the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

The Prevention of Recurrent Episodes of Depression With Venlafaxine for Two Years (PREVENT) Study: Outcomes From the 2-Year and Combined Maintenance Phases

Prevention of Recurrent Episodes of Depression With Venlafaxine ER in a 1-Year Maintenance Phase From the PREVENT Study

Recognition and Diagnosis of Atypical Depression

Translating the Evidence on Atypical Depression Into Clinical Practice

Treating DSM-IV Depression with Atypical Features

Preventing Recurrent Depression: Long-Term Treatment for Major Depressive Disorder

ELSEWHERE:

FOLLOW US:

Michael E. Thase, MD

Case-Control Analyses of the Impact of Pharmacotherapy on Prospectively Observed Suicide Attempts and Completed Suicides in Bipolar Disorder: Findings From STEP-BD

Efficacy of Quetiapine Monotherapy for the Treatment of Depressive Episodes in Bipolar I Disorder: A Post Hoc Analysis of Combined Results From 2 Double-Blind, Randomized, Placebo-Controlled Studies

Transcranial Magnetic Stimulation in the Acute Treatment of Major Depressive Disorder: Clinical Response in an Open-Label Extension Trial

Management of Patients With Treatment-Resistant Depression

Comparing the Rapidity of Response During Treatment of Major Depressive Disorder With Bupropion and the SSRIs: A Pooled Survival Analysis of 7 Double-Blind, Randomized Clinical Trials

Self-Reported History of Manic/Hypomanic Switch Associated With Antidepressant Use: Data From the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

The Prevention of Recurrent Episodes of Depression With Venlafaxine for Two Years (PREVENT) Study: Outcomes From the 2-Year and Combined Maintenance Phases

Prevention of Recurrent Episodes of Depression With Venlafaxine ER in a 1-Year Maintenance Phase From the PREVENT Study

Recognition and Diagnosis of Atypical Depression

Translating the Evidence on Atypical Depression Into Clinical Practice

Treating DSM-IV Depression with Atypical Features

Preventing Recurrent Depression: Long-Term Treatment for Major Depressive Disorder

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles